CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer.
Filippone MG, Gaglio D, Bonfanti R, Tucci FA, Ceccacci E, Pennisi R, Bonanomi M, Jodice G, Tillhon M, Montani F, Bertalot G, Freddi S, Vecchi M, Taglialatela A, Romanenghi M, Romeo F, Bianco N, Munzone E, Sanguedolce F, Vago G, Viale G, Di Fiore PP, Minucci S, Alberghina L, Colleoni M, Veronesi P, Tosoni D, Pece S.
Filippone MG, et al. Among authors: pennisi r.
Nat Commun. 2022 May 12;13(1):2642. doi: 10.1038/s41467-022-30375-8.
Nat Commun. 2022.
PMID: 35550508
Free PMC article.
Clinical Trial.